Company intelligence / Profile preview

Diagnósticos da América

Barueri, São Paulo, Brazil

Ownership: Private
Employees: ~18142
Development stage: Other

Overview

Diagnósticos da América (DASA) is a Brazil-based clinical diagnostics company founded in 1961. It offers approximately 3,000 types of examinations, including laboratory tests and imaging services, across Brazil and Argentina, operating under various diagnostic brands such as Alvaro and Delboni Auriemo. DASA recently entered a 50/50 hospital operations joint venture with Amil in 2024, involving 25 hospitals and several oncology clinics. The company is publicly traded on the B3 exchange (DASA3) and employs over 18,000 people.

Industry: Non-Academic Healthcare

Partnerships

Amil (50/50 hospital operations joint venture as of 2024)

Beyond the preview

Go deeper on Diagnósticos da América.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diagnósticos da América.

Explore the full profile